Xinli Shi
- Co-authors
- Li WangLiyuan HaoJianchun LiQing PengJingmin JiShenghao LiZhiqin ZhangNan Mao
- Topics
- Hippo pathway signaling and YAP/TAZ (15 papers)Autophagy in Disease and Therapy (11 papers)Ubiquitin and proteasome pathways (8 papers)
In The Last Decade
Xinli Shi
47 papers receiving 764 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 398
- Immunology 165
- Epidemiology 155
- Oncology 139
- Cell Biology 111
Countries citing papers authored by Xinli Shi
This map shows the geographic impact of Xinli Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinli Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinli Shi more than expected).
Fields of papers citing papers by Xinli Shi
This network shows the impact of papers produced by Xinli Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinli Shi. The network helps show where Xinli Shi may publish in the future.
Co-authorship network of co-authors of Xinli Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Xinli Shi. A scholar is included among the top collaborators of Xinli Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinli Shi. Xinli Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 5 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 14 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 10 | |
| 12 | 27 | |
| 13 | Antitumor effect of dihydroartemisinin on hypopharyngeal cancer in nude mice with transplanted tumor. | 3 |
| 14 | 42 | |
| 15 | 37 | |
| 16 | 12 | |
| 17 | 18 | |
| 18 | 11 | |
| 19 | 12 | |
| 20 | 27 |
About Xinli Shi
Xinli Shi is a scholar working on Cell Biology, Biochemistry and Immunology, having authored 50 papers that have together received 767 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (15 papers), Autophagy in Disease and Therapy (11 papers) and Ubiquitin and proteasome pathways (8 papers). The work is most often cited by research in Immunology (165 citations), Cell Biology (111 citations) and Cancer Research (94 citations). Xinli Shi has collaborated with scholars based in China, Australia and Hong Kong. Frequent co-authors include Li Wang, Liyuan Hao, Jianchun Li, Qing Peng, Jingmin Ji, Shenghao Li, Shenghao Li, Zhiqin Zhang, Nan Mao and Yajing Sun. Their work appears in journals such as The FASEB Journal, Frontiers in Immunology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.